PMID- 20424638 OWN - NLM STAT- MEDLINE DCOM- 20101019 LR - 20211020 IS - 1559-7016 (Electronic) IS - 0271-678X (Print) IS - 0271-678X (Linking) VI - 30 IP - 9 DP - 2010 Sep TI - Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia. PG - 1651-60 LID - 10.1038/jcbfm.2010.50 [doi] AB - Hyperbaric oxygen (HBO) and normobaric hyperoxia (NBO) protect the brain parenchyma and the cerebral microcirculation against ischemia. We studied their effect on secondary hemorrhage after thrombolysis in two thromboembolic middle cerebral artery occlusion (MCAO) (tMCAO) models. Beginning 60 minutes after tMCAO with either thrombin-induced thromboemboli (TT) or calcium-induced thromboemboli (CT), spontaneously hypertensive rats (n=96) breathed either air, 100% O(2) (NBO), or 100% O(2) at 3 bar (HBO) for 1 hour. Immediately thereafter, recombinant tissue plasminogen activator (rt-PA, 9 mg/kg) was injected. Although significant reperfusion was observed after thrombolysis in TT-tMCAO, vascular occlusion persisted in CT-tMCAO. In TT-tMCAO, NBO and HBO significantly reduced diffusion-weighted imaging-magnetic resonance imaging (MRI) lesion volume and postischemic blood-brain barrier (BBB) permeability on postcontrast T1-weighted images. NBO and, significantly more potently, HBO reduced macroscopic hemorrhage on T2* MRI and on corresponding postmortem cryosections. Oxygen therapy lowered hemoglobin content and attenuated activation of matrix metalloproteinases in the ischemic hemisphere. In contrast, NBO and HBO failed to reduce infarct size in CT but both decreased BBB damage and microscopic hemorrhagic transformation. Only HBO reduced hemoglobin extravasation in the ischemic hemisphere. In conclusion, NBO and HBO decrease infarct size after thromboembolic ischemia only if recanalization is successful. As NBO and HBO also reduce postthrombolytic intracerebral hemorrhage, combining the two with thrombolysis seems promising. FAU - Sun, Li AU - Sun L AD - Department of Neurology, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany. FAU - Zhou, Wei AU - Zhou W FAU - Mueller, Christian AU - Mueller C FAU - Sommer, Clemens AU - Sommer C FAU - Heiland, Sabine AU - Heiland S FAU - Bauer, Alexander T AU - Bauer AT FAU - Marti, Hugo H AU - Marti HH FAU - Veltkamp, Roland AU - Veltkamp R LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100428 PL - United States TA - J Cereb Blood Flow Metab JT - Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism JID - 8112566 RN - 0 (Fibrinolytic Agents) RN - 0 (Hemoglobins) RN - 9000-70-8 (Gelatin) RN - EC 3.4.21.5 (Thrombin) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) SB - IM MH - Animals MH - Blood-Brain Barrier MH - Brain Ischemia/*complications/*drug therapy/pathology MH - Cerebral Hemorrhage/etiology/pathology/*prevention & control MH - Data Interpretation, Statistical MH - Erythrocytes/physiology MH - Fibrinolytic Agents/*adverse effects MH - Gelatin MH - Hemoglobins/metabolism MH - Image Processing, Computer-Assisted MH - Infarction, Middle Cerebral Artery/complications/drug therapy/pathology MH - Magnetic Resonance Imaging MH - Male MH - Matrix Metalloproteinase 9/biosynthesis MH - *Oxygen Inhalation Therapy MH - Rats MH - Rats, Sprague-Dawley MH - Thrombin MH - Thromboembolism/chemically induced/*complications/*drug therapy PMC - PMC2949252 EDAT- 2010/04/29 06:00 MHDA- 2010/10/20 06:00 PMCR- 2011/09/01 CRDT- 2010/04/29 06:00 PHST- 2010/04/29 06:00 [entrez] PHST- 2010/04/29 06:00 [pubmed] PHST- 2010/10/20 06:00 [medline] PHST- 2011/09/01 00:00 [pmc-release] AID - jcbfm201050 [pii] AID - 10.1038/jcbfm.2010.50 [doi] PST - ppublish SO - J Cereb Blood Flow Metab. 2010 Sep;30(9):1651-60. doi: 10.1038/jcbfm.2010.50. Epub 2010 Apr 28.